Total Intravenous Anesthesia Versus Sevoflurane Anesthesia for Endovascular Thrombectomy in Acute Ischemic Stroke
Launched by TAIPEI VETERANS GENERAL HOSPITAL, TAIWAN · Aug 7, 2022
Trial Information
Current as of September 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the best type of anesthesia to use during a procedure called endovascular thrombectomy, which is performed on patients experiencing an acute ischemic stroke caused by a blocked blood vessel in the brain. The trial compares two different methods of general anesthesia: one using a gas called sevoflurane and the other using a medication called propofol delivered through an IV. Researchers want to see which method leads to fewer problems like confusion or memory issues after the procedure.
To participate in this trial, you need to be between 20 and 90 years old and diagnosed with a specific type of stroke that requires thrombectomy. You should also be willing to sign consent to join the study. If you choose to participate, the team will closely monitor your anesthesia and blood pressure during the procedure to ensure your safety and comfort. This study aims to find the best anesthesia approach for patients in similar situations, potentially improving recovery after strokes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of acute ischemic stroke with large vessel occlusion who are scheduled to undergo endovascular thrombectomy procedure, and
- • Must be age of 20 to 90
- • Must fulfill the indications for endovascular thrombectomy in acute ischemic stroke according to the American Heart Association/American Stroke Association 2018 Guidelines for the early management of patients with acute ischemic stroke and 2019 Taiwan stroke society guideline for endovascular thrombectomy in acute ischemic stroke, and
- • Must agree to enroll into the clinical trial and sign the written informed consent from patients or delegates
- Exclusion Criteria:
- • Allergy to allergy to the anesthetics used in this clinical study
- • Refusal for enrolling in study
About Taipei Veterans General Hospital, Taiwan
Taipei Veterans General Hospital, located in Taiwan, is a renowned medical institution dedicated to providing comprehensive healthcare and advancing medical research. As a prominent clinical trial sponsor, the hospital is committed to exploring innovative therapies and improving patient outcomes through rigorous scientific studies. With a multidisciplinary team of experienced researchers and clinicians, Taipei Veterans General Hospital prioritizes ethical standards and patient safety while contributing to the global medical community's knowledge base. Its state-of-the-art facilities and collaborative environment foster groundbreaking research that aims to address pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, Taiwan
Patients applied
Trial Officials
Hsu Ma, MD, PhD
Study Chair
Institutional Review Board, Taipei Veterans General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials